8 U.S. lawmakers have disclosed 17 West Pharmaceutical Services, Inc. trades under the STOCK Act — 13 buys and 4 sells between 2013 and 2025. Congress has been net buyers of WST, and their disclosed buys are down 2.5% versus the latest close.
*Notional-weighted price return on lawmakers' disclosed buys of WST, marked to the latest close — per-share (share counts aren't disclosed).
| Date | Member | Type | Amount | Est. price | Latest close | Return |
|---|---|---|---|---|---|---|
| 2025-02-13 | Jared Moskowitz | SELL | $1K–$15K | $199.11 | $346.16 2026-08-13 | -43.9% rt |
| 2023-12-28 | Jared Moskowitz | BUY | $1K–$15K | $354.93 | $346.16 2026-08-13 | -2.5% |
| 2022-03-30 | Thomas H Tuberville | SELL | $1K–$15K | $418.01 | $346.16 2026-08-13 | +49.0% rt |
| 2021-03-29 | Thomas H Tuberville | BUY | $1K–$15K | $280.51 | $346.16 2026-08-13 | +23.4% |
| 2020-09-24 | Greg Gianforte | SELL | $50K–$100K | $263.64 | $346.16 2026-08-13 | +115.1% rt |
| 2018-09-25 | Greg Gianforte | BUY | $50K–$100K | $122.59 | $346.16 2026-08-13 | +182.4% |
| 2018-09-20 | James B. Renacci | BUY | $1K–$15K | $120.10 | $346.16 2026-08-13 | +188.2% |
| 2018-08-21 | James B. Renacci | BUY | $1K–$15K | $115.96 | $346.16 2026-08-13 | +198.5% |
| 2018-04-30 | Lamar Smith | BUY | $1K–$15K | $88.21 | $346.16 2026-08-13 | +292.4% |
| 2018-01-18 | Lamar Smith | BUY | $1K–$15K | $98.59 | $346.16 2026-08-13 | +251.1% |
| 2017-10-23 | Lamar Smith | BUY | $1K–$15K | $92.51 | $346.16 2026-08-13 | +274.2% |
| 2017-05-31 | James B. Renacci | BUY | $1K–$15K | $97.02 | $346.16 2026-08-13 | +256.8% |
| 2015-07-22 | James B. Renacci | BUY | $1K–$15K | $61.50 | $346.16 2026-08-13 | +462.9% |
| 2015-05-11 | Kenny Marchant | BUY | $1K–$15K | $53.98 | $346.16 2026-08-13 | +541.3% |
| 2015-03-10 | James B. Renacci | BUY | $1K–$15K | $53.87 | $346.16 2026-08-13 | +542.6% |
| 2015-02-13 | Thomas R Tillis | SELL | $1K–$15K | $51.35 | $346.16 2026-08-13 | -574.1% exit |
| 2013-06-13 | SUSAN M COLLINS | BUY | $1K–$15K | $33.69 | $346.16 2026-08-13 | +927.6% |
Return: buys marked to the latest close (open); sells tagged rt are realized round-trips vs a prior disclosed buy; exit = timing (stock move after the sale, seller's perspective).
8 members of the U.S. House and Senate have disclosed West Pharmaceutical Services, Inc. transactions under the STOCK Act — 13 purchases and 4 sales. The full member-by-member breakdown, with dates and dollar ranges, is in the table above.
No member of Congress has disclosed a WST purchase in the last 90 days. STOCK Act filings lag the trade by up to 45 days, so newer buys may still be pending disclosure.
Notional-weighted, lawmakers' disclosed WST buys are down 2.5% versus the latest close of $346.16. Each trade's own return — and realized round-trips on matched sells — is in the Return column.
Yes. Under the 2012 STOCK Act, members of Congress may buy and sell individual stocks but must publicly disclose each transaction within 45 days. Bargo surfaces those filings so you can see who traded WST and how it performed.